Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00711815 · ClinicalTrials.gov registry record
A Study to Identify Markers in Blood and Tissue of HPV Clearance
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 197
- Enrollment target
NCT00711815: Completed study, sponsored by University of Alabama at Birmingham.
NCT00711815 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 197 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00711815 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
This is a research study looking at gene characteristics in blood and Pap smear samples in hopes of identifying markers that will predict if the HPV infection is present or not.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-11 |
What the finished NCT00711815 record still lists
NCT00711815 is an observational study that tracks outcomes without assigning an intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00711815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00711815 about?
NCT00711815 is a clinical study titled "A Study to Identify Markers in Blood and Tissue of HPV Clearance". This is a research study looking at gene characteristics in blood and Pap smear samples in hopes of identifying markers that will predict if the HPV infection is present or not.
What is the current status of trial NCT00711815?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2007-01. Estimated completion is 2010-11.
Who is sponsoring clinical trial NCT00711815?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04219254 · 197 participants · Phase 1
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- NCT06173778 · 197 participants · Phase 2
Semaglutide for Post-Smoking Cessation Weight Management
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia